Expanding patient volumes and a growing focus on non-opioid pain management will drive growth in the US pain management device market over the forecast period, although the market continues to be hindered by reimbursement challenges and pricing pressures.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for pain management devices in the US across a 10-year period.
Pain management procedures are increasingly being carried out in alternate care settings.
How are competitors adjusting their marketing strategies to reflect this trend?
What factors are influencing the purchasing decisions of pain specialists in alternate care facilities?
Infusion pain pumps are generating large revenues due to high volumes of cancer and postoperative pain patients.
What features are facilities prioritizing when they purchase new infusion pumps?
How are care providers using HCIT functions to improve delivery of infusion pain therapy?
SCS devices and RF ablation devices are experiencing uptake as late-stage therapies for back pain.
What factors are driving adoption of these devices?
What are manufacturers in other back pain treatment device segments are doing to remain competitive?
- Pain Management Devices - Market Insights - United States
Author(s): Dhara Patel, MS Pharm
Dhara Patel is a research associate on the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in capital equipment such as infusion systems and healthcare IT markets. Dhara holds a Bachelor's degree in Pharmaceutical Sciences from the University of Mumbai and a Master's degree in Medicinal Chemistry from the National Institute of Pharmaceutical Education and Research, Mohali.